Regorafenib beyond the Second Line in Relapsed Glioblastoma: A Case Report and Literature Review.
Case Rep Oncol
; 15(2): 642-647, 2022.
Article
in En
| MEDLINE
| ID: mdl-35949909
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Case Rep Oncol
Year:
2022
Document type:
Article
Affiliation country: